# Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient Selection

> **NCT00831454** · — · COMPLETED · sponsor: **Armando Santoro, MD** · enrollment: 51 (actual)

## Conditions studied

- NON-SMALL-CELL LUNG CANCER

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00831454
- **Lead sponsor:** Armando Santoro, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2014-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00831454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00831454, "Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient Selection". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00831454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*